RNAC R&D Expenses
Cartesian Therapeutics Inc · R&D Expenses
RNAC R&D Expenses
Latest reported$20.43Mperiod ending
RNAC Quarterly R&D Expenses ($4.97M → $20.43M)
Quarterly R&D Expenses
High-resolution chart · PNG
RNAC r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 20,431,000 | |
| 19,463,000 | |
| 14,689,000 | |
| 13,802,000 | |
| 14,869,000 | |
| 14,674,000 | |
| 11,306,000 | |
| 11,400,000 | |
| 12,661,000 | |
| 9,738,000 | |
| 22,431,000 | |
| 13,002,000 | |
| 17,782,000 | |
| 18,624,000 | |
| 18,967,000 | |
| 16,539,000 | |
| 19,182,000 | |
| 17,689,000 | |
| 20,318,000 | |
| 20,951,000 | |
| 14,463,000 | |
| 13,004,000 | |
| 15,091,000 | |
| 13,960,000 | |
| 10,730,000 | |
| 14,724,000 | |
| 15,152,000 | |
| 8,104,000 | |
| 12,134,000 | |
| 7,353,000 | |
| 10,256,000 | |
| 11,885,000 | |
| 14,407,000 | |
| 11,139,000 | |
| 13,623,000 | |
| 9,504,000 | |
| 10,994,000 | |
| 11,044,000 | |
| 11,033,000 | |
| 6,021,000 | |
| 6,000,000 | |
| 6,648,000 | |
| 7,211,000 | |
| 5,483,000 | |
| 5,314,000 | |
| 4,972,000 |